PTK2 and cancer: In CCA etiology, assessment of TNF-α is varied; it promoted cancer cell invasiveness by MMP-9 through the activation of MAPK and ERK1/2 with cancer cell by MMP-9 through the activation of MAPK and ERK1/2 with metabolites FAK and COX-2 [21].